Ying Taur, MD, MPH

Education:
MD, MPH: New York Medical College
View Ying Taur’s physician profile.

I am interested in the epidemiology of infections which occur in the setting of complex patients such as those with cancer. Complicated patients who have multiple pre-existing conditions represent a challenge to treat but also to study in clinical research. I am investigating new methods designed to examine infections within their natural clinical setting and to provide unbiased estimates of their impact on patient outcomes.

Publications by Ying Taur

Taur Y, Cohen N, Dubnow S, Paskovaty A, Seo SK. Effect of antifungal therapy timing on mortality in cancer patients with candidemia. Antimicrob Agents Chemother 2010;54:184-190. Epub 2009 Nov 2. [PubMed Abstract]

Jathavedam A, Duré DC, Taur Y, Weinstock DM. Limited utility of serum galactomannan assay after auto-SCT. Bone Marrow Transplant. 2009 Jul;44(1):59-61. No abstract available

Jathavedam A, Dure DC, Taur Y, Weinstock DM. Limited utility of serum galactomannan assay after auto-SCT. Bone Marrow Transplant 2009 Jan 12. [PubMed Abstract]

Mihu CN, King E, Yossepovitch O, et al. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation. Transpl Infect Dis 2008 Jun;10(3):162-7. [PubMed Abstract]

Taur Y, Smith MA. Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection. Clin Infect Dis 2007 Mar 15;44(6):769-74. [PubMed Abstract]

Hassoun A, Taur Y, Singer C. Evaluation of thin needle aspiration biopsy in the diagnosis and management of vertebral osteomyelitis (VO). Int J Infect Dis 2006 Nov;10(6):486-7. [PubMed Abstract]

View Ying Taur's physician profile.